Yuyu Pharma, Inc. (KRX:000220)

Market Cap	60.47B -20.8%
Revenue (ttm)	140.88B +5.8%
Net Income	7.83B -6.5%
EPS	481.00 -6.2%
Shares Out	15.75M
PE Ratio	7.98
Forward PE	n/a
Dividend	115.00 (2.98%)
Ex-Dividend Date	Dec 29, 2025

Volume	45,403
Average Volume	62,156
Open	3,865.00
Previous Close	3,835.00
Day's Range	3,830.00 - 3,945.00
52-Week Range	3,805.00 - 5,100.00
Beta	0.38
RSI	26.93
Earnings Date	Apr 3, 2026

About Yuyu Pharma

Yuyu Pharma, Inc. develops and markets pharmaceutical products. The company offers various prescription drugs, including osteoporosis, brainbone metabolism-hypocalcemia improvement, cerebral and peripheral circulatory disturbance, tromboembolism, respiratory organ, hypertension, pulmonary tuberculosis therapy, arthrifuge, diabetic neuropathy therapy, eczematous dermatitis drugs, and other circulatory system drugs, as well as antibiotics and skeletal muscle relaxants. It also provides non-prescription drugs and health supplements. The company wa...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1941
• Country: South Korea
• Stock Exchange: Korea Stock Exchange
• Ticker Symbol: 000220

Financial Performance

In 2025, Yuyu Pharma's revenue was 140.88 billion, an increase of 5.81% compared to the previous year's 133.15 billion. Earnings were 7.83 billion, a decrease of -10.21%.